# Pioglitazone

## Actos 30mg

#### 一般可用

| 藥品代碼       | OACT3                                                                                                                                                                                                                                                                                                                                                                       |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Monotherapy or in combination with sulphonylureas， metformin or insulin in patients with type II diabetes.                                                                                                                                                                                                                                                                 |
| 用法用量       | 15-30 mg once daily， max 45 mg/day.                                                                                                                                                                                                                                                                                                                                        |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                |
| 禁忌           | Type 1 diabetes， diabetic ketoacidosis. Active hepatic disease or ALT levels > 2.5 times the upper limit of normal. NYHA class III or IV heart failure.                                                                                                                                                                                                                    |
| 副作用         | Edema， upper respiratory tract infection， headache， myalgia. Cardiovascular: Edema (4.8% to 15.3% ) Endocrine metabolic: Weight gain Hematologic: Anemia (less than or equal to 2% ) Musculoskeletal: Fracture of bone (5.1% )， Myalgia (5.4%) Neurologic: Headache (9.1% ) Respiratory: Pharyngitis (5.1% )， Sinusitis (6.3% )， Upper respiratory infection (13.2% ) |
| 孕期用藥建議   | No (limited) human data – animal data suggest moderate risk                                                                                                                                                                                                                                                                                                                 |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                         |

